(30), enriched and differentiated CD34- cells were derived from patients with CML for metabolic analyses on each CD34+CD38- stem cell, it has been proven that most primitive LSCs have higher mitochondrial efficacy than differentiated LSCs and normal CD34+CD38- cells. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.